About Lifecore
Lifecore is a publicly listed company based in Chaska (United States) founded in 1965, and was acquired by Landec in April 2010. It operates as a hyaluronan-based products for biomedical applications are developed. The company has 406 employees. Lifecore offers products and services including Process Development, Clinical Manufacturing, Analytical Services, and Sodium Hyaluronate. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and API Production. Its legal entity is LANDEC CORP CA. Its competitors include Bloomage Biotechnology, Fidia Farma, Contipro, Qingdao Kangyuan Pharmaceutica and Altergon Italia and 4 more.
Company details
Lifecore Biomedical, a wholly owned subsidiary of Landec Corporation (Nasdaq: LNDC), is dedicated to the development of technically advanced hyaluronan-based products that offer long-term compatibility with the human body. Since 1986, more than 50 million patients worldwide have benefited from Lifecores innovations in sodium hyaluronate products. The companys products meet or exceed the highest standards set by the United States Food and Drug Administration, the European Community and other international agencies. The Lifecore facility is ISO 13485 and GMP certified, international symbols of quality system assurance and compliance.
- Headquarters Chaska, United States
- Employees 406
- Stage Public
- SectorsHealthcare
- Email••••••••
- Website lifecore.com
- Social LinkedIn Facebook
- Acquired by Landec (Apr 2010)
- Legal Name Lifecore Biomedical, Inc.
- Annual Revenue$128.87 M (USD)0.47as on May 31, 2025
- Net Profit-$38.72 M (USD)-422.29as on May 31, 2025
- EBITDA-$3.98 M (USD)-590.02as on May 31, 2025
- Latest Funding Round$24.3M (USD), Post-IPO
Oct 2024
- InvestorsWynnefield Capital
& 1 more
- Employee Count406
- Acquired byLandec
(Apr 2010)
Products & Services of Lifecore
Lifecore offers a comprehensive portfolio of products and services, including Process Development, Clinical Manufacturing, Analytical Services, and Sodium Hyaluronate.
Services for scaling drug products from concept to commercial supply.
Production and packaging of injectable medical devices and pharmaceuticals.
On-site labs for sample analysis and stability testing.
Non-animal-sourced hyaluronate for research and commercial applications.
Funding Insights of Lifecore
- Total Rounds 4
- Last Round Post-IPO — $24.3M
- First Round $19.36M
(Dec 2018)
- Investors Count 1
All 4 funding rounds of Lifecore with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2024 | $24.3M | Post-IPO | – | – | – |
| Nov 2022 | $5M | Post-IPO | – | – | |
| Oct 2019 | $220M | Debt – Conventional | – | – | – |
| Dec 2018 | $19.36M | Post-IPO | – | – | – |
2 investors in total: 2 institutional.
Investors in Lifecore
Lifecore has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Wynnefield Capital and Landec.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Manages investment funds for sophisticated financial investors worldwide. | 1992 | wynnecap.com | New York, United States | |
- | – | landec.com | - |
Investor details for Lifecore
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Lifecore
38 people are tracked at Lifecore (14 in leadership, 24 in team); the tracked headcount is 406.
| Name | Role | Group |
|---|---|---|
Suwanna Lee | IT Director - Applications | Leadership |
Michael Dorsey | Vice President & Corporate Controller | Leadership |
Jessica Raddatz Hensley | Director Of Quality Control | Leadership |
Jackie Klecker | Executive Vice President, Quality And Development Services, | Leadership |
Scott Collins | Vice President Of Finance | Leadership |
Phil Sticha | Vice President Of Development Services | Leadership |
Richard Sitarz | VP Of Commercial Development | New Business Development, Strategic Planning, Customer Engagement | Leadership |
Bryan Malmquist | Director Of Information Technology | Leadership |
Rachel Smisek | Director Information Technology Architecture | Leadership |
Rick Sitarz | VP Of Commercial Development | New Business Development, Strategic Planning, Customer Engagement | Leadership |
Brianna Pena | Quality Assurance Director | Leadership |
Matt Augustson | Senior Vice President Of Information Technology | Leadership |
Tom Salus | Chief Legal And Administration Officer And Corporate Secretary | Leadership |
Carla Lusby | VP Of Finance Transformation | Leadership |
Kamlesh Patel | Principal Scientist | Team |
Jeff Schunk | QC Chemistry Manager | Team |
Erica Flinn | QC Microbiology Supervisor | Team |
Hong Nguyen | Senior Stability Specialist | Team |
Mike Puzak | Facility Manager | Team |
Heather Schmidt | Principal Quality System Specialist | Team |
18 more people are available in the full profile.
Complete people profiles for Lifecore
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Lifecore
Lifecore is a publicly listed company on the NASDAQ with ticker symbol LFCR in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date25 Mar 2021
- Listed onNASDAQ: LFCR
- Listed entityLifecore Biomedical, Inc.
- Exchange sectorHealth technology
- ISINUS5147661046
- Share price$6.42 (-0.31% on the day) · 2026-10-13
- Market capitalisation$243.4M
- Volume (last session)590,630
Financials of Lifecore
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2024 | $128.9M | -$38.7M | -$4.0M |
| 2023 | $128.3M | $12.0M | $812,000 |
| 2022 | $103.3M | -$99.6M | -$9.4M |
| 2021 | $111.3M | -$117.0M | $3.7M |
| 2020 | $171.6M | -$32.7M | $14.0M |
Detailed financial statements for Lifecore
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Lifecore
5 dated milestones of Lifecore across 59 years, from founding to its latest funding, stage changes and deals.
- Founded Lifecore is founded.
- Exit Acquired by Landec.
- Funding First funding round of $19.4M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $24.3M.
Competitors of Lifecore
Lifecore has 9 listed competitors in our database. They include Bloomage Biotechnology, Fidia Farma, Contipro, Qingdao Kangyuan Pharmaceutica and Altergon Italia, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bloomagebioactive.com | 1998 | Jinan, China | – | – | Manufacturer of hyaluronic acid & pharmaceutical products | |
| fidiapharma.com | 1946 | Abano Terme, Italy | – | – | Proprietary hyaluronic acid treatments and derivatives are developed. | |
| contipro.com | 1990 | Pardubice, Czech Republic | – | – | Manufacturer of hyaluronic acid-based products | |
| kangyuan.com.cn | 2001 | Qingdao, China | – | – | Operates as a CDMO specializing in hyaluronidase manufacturing. | |
| altergon.it | 2000 | Avellino, Italy | – | – | Develops and manufactures pharmaceutical products and medical devices for clients. | |
| mxpharm.com | 2005 | Tianjin, China | – | – | CDMO focused on manufacturer of API drugs | |
| viablife.com | 2015 | Hangzhou, China | – | – | APIs are produced by Viablife as a CDMO in pharmaceuticals. | |
| ildonghyaltech.com | 2016 | Cheongju-si, South Korea | – | – | Delivers contract-based manufacturing services for hyaluronic acid products. | |
| junuvcp.com | 2015 | India | – | – | Exports active pharmaceutical ingredients and chemicals worldwide via online platform. |
Detailed competitors of Lifecore
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Lifecore
The website of Lifecore (lifecore.com) receives about 6.8K visits a month.
- Monthly visits6.8K
▲ 43.1% vs previous month
Websites whose visitors overlap most with Lifecore. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| keystonedental.com | 100% | 8K | #1,899,144 | View details | |
| lexionmedical.com | 83% | – | #6,386,828 | View details | |
| straumann.com | 82% | 554K | #69,793 | View details | |
eclmedical.com | eclmedical.com | 79% | – | – | – |
esquire.it | esquire.it | 79% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 27 similar websites and full traffic analytics for Lifecore
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 27 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Lifecore (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Lifecore
Complete news archive for Lifecore
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lifecore
Lifecore was founded in 1965 and raised its 1st funding round 53 years after it was founded.
Lifecore is headquartered in Chaska, United States. It is registered at Chaska, Minnesota, United States.
Lifecore has 406 employees.
Annual revenue of Lifecore is $128.87M as on May 31, 2025.
Lifecore Biomedical, a wholly owned subsidiary of Landec Corporation (Nasdaq: LNDC), is dedicated to the development of technically advanced hyaluronan-based products that offer long-term compatibility with the human body. Since 1986, more than 50 million patients worldwide have benefited from Lifecores innovations in sodium hyaluronate products. The companys products meet or exceed the highest standards set by the United States Food and Drug Administration, the European Community and other international agencies. The Lifecore facility is ISO 13485 and GMP certified, international symbols of quality system assurance and compliance.
Lifecore's top competitors include Bloomage Biotechnology, Fidia Farma and Contipro.
Lifecore offers Process Development, Clinical Manufacturing, Analytical Services, and Sodium Hyaluronate.
Yes, Lifecore is publicly traded on NASDAQ under the ticker symbol LFCR.
Lifecore has 2 investors. Key investors include Wynnefield Capital, and Landec.
Lifecore operates through Landec Corp Ca.
Yes. Lifecore was acquired by Landec in April 2010.